Overview
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 519 days for 2021).
- 202510/08/2026
- 202410/06/2025
- 202320/11/2024
- 202216/12/2023
- 202116/12/2023
- 202008/03/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The following are authorized to make declarations of will concerning the rights and obligations of the company, to sign agreements and to incur liabilities on behalf of the company: in the case of a one-person management board, the President of the Management Board independently, and in the case of a multi-member management board, two members of the management board or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Jagielskiage 44 | 300 | $8,103.73 | 30% |
Dariusz Młynarskiage 57 | 300 | $8,103.73 | 30% |
Rafał Pudyszakage 51 | 400 | $10,804.97 | 40% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-07-23.
14 1090 2590 0000 0001 4447 6007
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $20,593.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 31, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezydent Miasta Gdynia | |
| Aug 31, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezydent Miasta Gdynia | |
| Jun 21, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezydent Miasta Gdynia |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DigitmedS.A. | $382,907.91 | digitmed.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Wstechnologysp. z o.o. | $258,318.71 | wstechnology.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com |
FAQ
Last updated: 2026-10-03